Halozyme Therapeutics, Inc.
HALOBiotechnologyClosed
102.88-7.4%Up to 1000x leverageTrade HALO
What it reported
Reported 5 days ago, on 2026-11-05.
Forecast against the result
| Forecast | Reported | Surprise | |
|---|---|---|---|
| Revenue | 491.6M | 493.0M+39.2% year on year | +0.3% |
| Net income | 282.6M | 247.0M+41.0% year on year | -12.6% |
| Earnings per share | 2.30 | 2.39+39.0% year on year | +3.9% |
Year on year compares the same quarter a year earlier (2025-11-03), not the quarter before.
HALO trades at up to 1000x here. At 1000x, a 0.10% move against you wipes out the whole margin. This ignores fees, funding and maintenance margin, all of which bring liquidation forward. Your actual liquidation price is the one shown on the order page.
You can hold through the announcement here
HALO is quoted here 24 hours a day and does not stop when the US market closes. On a US exchange the same news only shows up as a gap at the next open.
What the market expects
For the quarter ending 2026-12-30.
Against the same quarter last year (2026-02-17): EPS +1165.7%revenue +19.0%
These are third-party analyst forecasts. CoinUnited.io does not produce them and does not choose which analysts are included.
Where the revenue comes from
- Royalty50.2%341.0M
- Product35.7%242.7M
- Bulk rHuPH2010.4%70.6M
- Collaborative Agreements2.2%14.6M
- Sales-based Milestone1%7.0M
- Upfront Fees0.4%3.0M
Most recent reported quarter (2026-09-30).
Track record
Next report expected 2027-02-16. Reports quarterly.
Beat estimates 7 of the last 8 quarters. The typical gap is +0.09 per share.
Where analysts put it in 12 months
A different timescale from the rest of this page: these are 12-month views, not the two-day move around a report.
| Firm | Target | Set on | Source |
|---|---|---|---|
| Stifel Nicolaus | 130.00 | 2026-10-16 | StreetInsider |
| H.C. Wainwright | 130.00 | 2026-10-08 | TheFly |
| Wells Fargo | 95.00 | 2026-08-10 | TheFly |
| Morgan Stanley | 105.00 | 2026-08-07 | TheFly |
| Leerink Partners | 110.00 | 2026-08-07 | TheFly |
| UBS | 90.00 | 2026-06-03 | StreetInsider |
From 6 firms that published a target in the last 180 days, latest call per firm. Targets are set by those firms; CoinUnited.io does not produce or endorse them.
Reported results
| Reported | EPS forecast | EPS actual | Surprise | Revenue surprise |
|---|---|---|---|---|
| 2026-11-05 | 2.3 | 2.39 | +3.9% | +0.3% |
| 2026-08-06 | 1.79 | 2.28 | +27.4% | +19.6% |
| 2026-05-11 | 1.55 | 1.6 | +3.2% | +5.0% |
| 2026-02-17 | 2.15 | -0.24 | -111.2% | +3.7% |
| 2025-11-03 | 1.63 | 1.72 | +5.5% | -20.7% |
| 2025-08-05 | 1.23 | 1.54 | +25.2% | -1.5% |
| 2025-05-06 | 0.95 | 1.11 | +16.8% | -5.7% |
| 2025-02-18 | 1.17 | 1.26 | +7.7% | +4.3% |
| 2024-10-31 | 0.98 | 1.27 | +29.6% | -0.9% |
| 2024-08-06 | 0.76 | 0.91 | +19.7% | +10.7% |
| 2024-05-07 | 0.7 | 0.79 | +12.9% | -2.0% |
| 2024-02-20 | 0.83 | 0.82 | -1.2% | -0.5% |
Also reporting this fortnight in Biotechnology
CYTK 
GMAB 
IOVA 
MRNA 
ROIV 
RVMD 3 more in Biotechnology
EPS history for HALO runs from 2002-05-15 to 2026-11-05, 90 reports.